Jiancheng Li

机构：Harbin Medical University, Yangtze University, First Affiliated Hospital of Bengbu Medical College · ORCID：0000-0003-3686-9958

发表论文 243 篇 · 总被引 3614 次 · h-index 29

代表论文

• CHAC1 blockade suppresses progression of lung adenocarcinoma by interfering with glucose metabolism via hijacking PKM2 nuclear translocation (2024 · Cell Death and Disease · 被引 11)
• Pirfenidone for grade 2 and grade 3 radiation-induced lung injury: a multicentre, open-label, randomised, phase 2 trial (2025 · The Lancet Oncology · 被引 10)
• Structural basis for ligand recognition of the human hydroxycarboxylic acid receptor HCAR3 (2024 · Cell Reports · 被引 9)
• Expression of interleukin-17 in oral tongue squamous cell carcinoma and its effect on biological behavior (2025 · Scientific Reports · 被引 7)
• A nomogram with Nottingham prognostic index for predicting locoregional recurrence in breast cancer patients (2024 · Frontiers in Oncology · 被引 4)
• Anlotinib promotes CD4 + T cell infiltration and enhances the anti-tumor effect of PD-1 blockade in lung cancer (2025 · Immunologic Research · 被引 3)